retatrutide clinical trial information Retatrutide: What It Is & How This New Drug Works Retatrutide, an investigational triple hormone
Description
EDP-305 is a novel oral FXR agonist under development for the treatment of MASH
There is ongoing research into how GLP-1 drugs like Wegovy contribute to blood clot formation, emphasizing the need for continuous monitoring and study
29 The randomized, double-blind study enrolled 1,864 participants with a mean baseline A1C of 8.3% and BMI of 32.5
Cropley V, Croft R, Silber B, Neale C, Scholey A, Stough C, Schmitt J
FDA Approves Weight Management Drug for Patients Aged 12 and Older
Verify the amount by holding the syringe at eye level
